Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer

Although TC2N has proven to be an oncogene in lung cancer, its biological function and molecular mechanisms in other cancer still remains unclear. Here, we investigate in breast cancer that TC2N expression is sharply overexpressed in breast cancer specimens compared with normal breast specimens, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Xiang-lin, Gao, Li-yun, Deng, Xiao-juan, Han, Fei, Chen, Hong-qiang, Jiang, Xiao, Liu, Wen-bin, Wang, Dan-dan, Chen, Jian-ping, Cui, Zhi-hong, Ao, Lin, Cao, Jia, Liu, Jin-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541591/
https://www.ncbi.nlm.nih.gov/pubmed/31142739
http://dx.doi.org/10.1038/s41419-019-1663-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541591/
https://www.ncbi.nlm.nih.gov/pubmed/31142739
http://dx.doi.org/10.1038/s41419-019-1663-5

Ejemplares similares